Showing results (931-940 of 3,492) with videos related to
Sort By:
Pageof 350
Archiv Der Pharmazie|November 16, 2011
N-(Imidazolidin-2-ylidene)-1-arylmethanamine oxides: synthesis, structure and pharmacological evaluationJarosław Saczewski, Alan Hudson, Shayna Laird, et al.Archiv Der Pharmazie|November 23, 2011
Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activityBraulio Insuasty, Leidy Chamizo, Jhon Muñoz, et al.Archiv Der Pharmazie|November 23, 2011
Synthesis and antimicrobial evaluation of new pyrano[4,3-b]pyran and Pyrano[3,2-c]chromene derivatives bearing a 2-thiophenoxyquinoline nucleusJigar A Makawana, Manish P Patel, Ranjan G PatelArchiv Der Pharmazie|September 30, 2011
Synthesis and biological evaluation of novel homocamptothecins conjugating with dihydropyrimidine derivatives as potent topoisomerase I inhibitorsLingjian Zhu, Pengfei Cheng, Ning Lei, et al.Archiv Der Pharmazie|September 30, 2011
SVEEVA descriptor application to peptide QSARJianbo Tong, Ting Che, Shuling Liu, et al.Archiv Der Pharmazie|September 30, 2011
Synthesis and biological evaluation of 4α/4β-imidazolyl podophyllotoxin analogues as antitumor agentsHai Shang, Hong Chen, Dongmei Zhao, et al.Archiv Der Pharmazie|September 29, 2011
Synthesis and cytotoxicity studies of novel 2-Hydrazonylpyrido[2,3-b]pyrazin-3(4H)-onesGuogang Zhang, Yajing Liu, Shuobing Wang, et al.Archiv Der Pharmazie|October 11, 2011
Anti-tumor activity of new artemisinin-chalcone hybridsLijun Xie, Xin Zhai, Chun Liu, et al.Archiv Der Pharmazie|December 23, 2011
Arylalkyl ketones, benzophenones, desoxybenzoins and chalcones inhibit TNF-α induced expression of ICAM-1: structure-activity analysisSarvesh Kumar, Chandra Shekhar Reddy L, Yogesh Kumar, et al.Archiv Der Pharmazie|July 1, 2009
Synthesis of dimeric quinazolin-2-one, 1,4-benzodiazepin-2-one, and isoalloxazine compounds as inhibitors of amyloid peptides associationAlexander Barthel, Lothar Trieschmann, Dieter Ströhl, et al.Pageof 350